Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.

Br J Cancer · 2011 · PMC3068506 · PMID 21386843

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP =0.07so close (0.05 < p ≤ 0.1)

However, the association between day 1 and day 14 changes in CD45 dim CD34 + VEGFR2 + progenitor cell levels and OS did not reach statistical significance ( P =0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.